Financials

  • Market Capitalization 3.97 M
  • Employee 10
  • Founded 2003
  • CEO N/A
  • Website www.ensysce.com
  • Headquarter Delaware, United States
  • FIGI BBG00JFF4174
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.23
Price to sales ratio
0.46

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
5049
SXTP
60 Degrees Pharmaceuticals, Inc. - Common Stock
1.51 USD-6.79%-17.93%+5.59%-33.77%4.02 M USD
5051
GOVX
GeoVax Labs, Inc. - Common Stock
1.15 USD-3.36%-8.00%-12.88%-20.69%3.99 M USD
5055
REVB
Revelation Biosciences, Inc. - Common Stock
0.97 USD-2.02%-6.73%-3.00%-29.71%3.79 M USD
5059
EVGN
Evogene Ltd. - Ordinary Shares
0.42 USD0.00%-4.55%-30.00%-70.42%3.66 M USD

Frequently asked questions about Ensysce Biosciences, Inc. - Common Stock

What is the Ensysce Biosciences, Inc. - Common Stock stock price today?

The current price of Ensysce Biosciences, Inc. - Common Stock (ENSC) is 0.27. Over the past 24 hours, the stock has changed by 0.00%. Follow the ENSC chart for real-time price dynamics.

What is the stock ticker of Ensysce Biosciences, Inc. - Common Stock?

Ensysce Biosciences, Inc. - Common Stock trades under the ticker ENSC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Ensysce Biosciences, Inc. - Common Stock stock going up?

ENSC has changed by -10.00% over the last week, +8.00% over the last month, and -29.41% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Ensysce Biosciences, Inc. - Common Stock net income for the last quarter?

Ensysce Biosciences, Inc. - Common Stock reported net income of -3.56 M for the last quarter. The previous quarter showed -2.77 M, which means net income changed by -28.48%.

How many employees does Ensysce Biosciences, Inc. - Common Stock have?

As of the latest available data, Ensysce Biosciences, Inc. - Common Stock has 10 employees. Workforce size can provide additional context about the company's scale and operations.

What is Ensysce Biosciences, Inc. - Common Stock EBITDA?

Ensysce Biosciences, Inc. - Common Stock EBITDA is -3.56 M, and its EBITDA margin is -370%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Ensysce Biosciences, Inc. - Common Stock stock?

You can buy Ensysce Biosciences, Inc. - Common Stock (ENSC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Ensysce Biosciences, Inc. - Common Stock stock?

Investing in Ensysce Biosciences, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ENSC chart and related analysis on metatrader.com as part of your research.

News